Navigation Links
Wyeth Pharmaceuticals Announces Organizational Change
Date:6/26/2008

- Andreas Krebs Named President of Europe/Middle East/Africa and Canada -

COLLEGEVILLE, Pa., June 26 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today the appointment of Andreas Krebs, 50, to President - Europe/Middle East/Africa and Canada, effective immediately. In this new role, Mr. Krebs will report to Joseph M. Mahady, President - Wyeth Pharmaceuticals, and Senior Vice President, Wyeth.

Mr. Krebs joined the Company in July 2003 as General Manager, Wyeth Germany, and since that time has worked to transform the German affiliate into one of the fastest growing companies in the market. He serves on the Board of the VFA (Germany's trade organization for research companies) and is a member of the Board of Trustees in the Max Planck Institute for Molecular Biomedicine and the Paul Ehrlich Society for Chemotherapy.

Prior to joining Wyeth, Mr. Krebs was with Bayer for approximately 20 years, where he held a variety of pharmaceutical marketing and sales leadership positions in Europe, Latin America, Asia and Canada. He holds a degree in Commercial Management and Business Administration from the In-House Academy of Woelm Pharma, Eschwege, Germany.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


'/>"/>
SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
2. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
3. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
4. Wyeth Chairman Robert Essner Announces June 27 Retirement
5. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
6. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
7. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
8. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
9. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
10. Wyeth Announces Executive Change in Finance Organization
11. Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...wire-FirstCall/ -- IES (Nasdaq: IESC ), a leading...s systems and services for the commercial, industr...its commercial business group has been awarded a c...ectrical systems for the Level 4 bio-safety lab (B...l Research Institute of Infectious Diseases (USAMR...
(Date:11/24/2009)...Iceland, November 24 deC... that it has received notice from,the Nasdaq Stock... will be,suspended as of November 30, 2009 and a F...xchange Commission, which will remove deCODE,s com...ny files an appeal to the Nasdaq,Listing Qualifica...
(Date:11/24/2009)...24 NeurogesX, Inc. (Nasd...n developing and commercializing novel pain manage...no, President and Chief Executive Officer, is sche...Health Care Conference, to be held December 1-2, 2...York. ,, Mr. DiTonno and Stephen Ghiglieri, Ch...
(Date:11/24/2009)...ONTO, Nov. 24 /PRNewswire-FirstCall/ - Hamilton Th...nc., a leading provider of advanced laser systems ...tility clinic markets, today reported operational ...September 30, 2009. , , Q3 2009 Highlights, ...3 million in Q3 2008, - Gross profit margin w...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10
... 11 Nektar Therapeutics,(Nasdaq: NKTR ) will an...r and,year ended December 31, 2008 on Wednesday, F...nancial markets. Howard Robin, president and chie...o review the results beginning at,5:00 p.m. Easter... press release and a live audio-only Webcast of th...
...b. 11 XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB...man and Mr. Boaz Shweiger have been appointed to X...tion, Mr. Grossman will also be assuming,the role ...n, to assist in,XTL,s analysis of its strategic al...Officer of XTL, commented, "We decided to,make the...
...entists engaged in biological research and drug di...9 lab budgets. BioInformatics, LLC ( www.gene2dru...rving the life science market, has released prelim...pering in a Down Market: Strategies for Life Scien... understand current sources of funding for researc...
Other Biology Technology:Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets 2XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors 2XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors 3Life Science Labs Reacting to the Economic Crisis 2
(Date:11/24/2009)...c-level action of a remarkable class of ring-shape... with the Lawrence Berkeley National Laboratory (B...tallography beamline at the Advanced Light Source ...gene expression and replication, and are vital to ...nfectious agents, such as the human papillomavirus...
(Date:11/24/2009)...stitutes fish food is a matter of debate. A high-p...et almost 50 percent of their carbon from trees an...he terrestrial and aquatic ecosystems. , But new...this is not likely to be true. Algae provide a muc...ording to research published this week in the Pro...
(Date:11/23/2009)...n, D.C. The community-associated strain of the de...sistant to most common antibioticsposes a far grea...ing its way into hospitals, according to a study i...ses . , The new threat is easily picked up in f...nd has increased the overall burden of MRSA within...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2pMDsoft Announces Interfaces with Additional EMR EHR Practice Management Hospital and Billing Systems 56507 1pMDsoft Announces Interfaces with Additional EMR EHR Practice Management Hospital and Billing Systems 56507 2pMDsoft Announces Interfaces with Additional EMR EHR Practice Management Hospital and Billing Systems 56507 3pMDsoft Announces Interfaces with Additional EMR EHR Practice Management Hospital and Billing Systems 56507 4pMDsoft Announces Interfaces with Additional EMR EHR Practice Management Hospital and Billing Systems 56507 5realbuzz com Top 25 Things to do Before You Die 56505 1realbuzz com Top 25 Things to do Before You Die 56505 2Details of DNC Fall Meeting in Austin 56503 1Details of DNC Fall Meeting in Austin 56503 2
...ng Acute Kidney Injury , Dr. Eisei Noiri and col...ed a novel biomarker to monitor acute kidney injur...e of The American Journal of Pathology . , Acu...ptly and appropriately. Novel biomarkers therefore...time points as well as to estimate the severity of...
...ing Australia,s most endangered snake might mean l... , The last remaining populations of broad-headed...nd that is destroying their habitat, a study by sc...d University (USA) has shown. , "Broad-headed sna...200 km of Sydney, and those small communities are ...
...per cored from layers 3.46 billion years old sugge...oxygen then, but that the atmosphere was as oxygen...This jasper or hematite-rich chert formed in ways ...rmal vents in the deep oceans today. , "Many peo...s formed by the oxidation of siderite in the moder...
Other Biology News:Tips from the American Journal of Pathology 2Tips from the American Journal of Pathology 3Tips from the American Journal of Pathology 4Tips from the American Journal of Pathology 5Australia's most endangered snake might need burning 2Deep-sea rocks point to early oxygen on Earth 2
Mouse GM-CSF ELISpot Development Kit from R&D Systems
...t contains the basic components required for the d...nd recombinant rat Thymus Chemokine-1 in cell cult...ient materials to run ELISAs on approximately fift...nditions are met: The assay is run as summarized...
Custom Conjugation Services from SoluLink
Rabbit Anti-Blimp-1 (H-150) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: